According to statistics, in 2022, the age-adjusted prevalence of diagnosed arthritis in adults was 18.9 per cent ... And so, losing at least 5 per cent of your current body weight is enough to have ...
Among patients receiving SC tocilizumab, body weight was correlated with a diminished treatment response based on changes in DAS28 values, with an adjusted regression coefficient of 0.01 (95% CI, ...
Results from a phase 2b trial (ClinicalTrials.gov Identifier: NCT04707313) showed treatment with danuglipron led to statistically significant reductions in body weight at all tested doses (40mg, 80mg, ...
Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.
Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...